期刊文献+

精制苦瓜提取物的制备及其降糖作用

Preparation of Refine Momordica Charactia L. Extract and its Effect on Rat with Streptozotocin-induced Diabetes
下载PDF
导出
摘要 目的:对苦瓜果汁进行精加工,得到去除其中性寒味苦成分的精制苦瓜提取物,并通过对2型糖尿病大鼠动物试验,比较未去苦味的苦瓜提取物粗品和除去苦味的精制苦瓜提取物的活性差异。方法:使用大孔树脂处理方法,得到无苦味的精制苦瓜提取物。大鼠高脂高糖饮食1个月后,ip链脲佐茵素诱导2型糖尿病。使用精制苦瓜提取物治疗2型糖尿病大鼠,测试其降糖活性作用。结果:精制苦瓜提取物没有苦味,性温;通过活性对比试验,精制苦瓜提取物和苦瓜提取物粗品对2型糖尿病大鼠作用6周后,大鼠体重均明显增加,血糖显著下降,两者无显著性差异。结论:采用大孔树脂吸附的方法既除去苦瓜提取物粗品中的苦味性寒成分,又未见其精制苦瓜提取物在降糖活性方面的明显损失。 Objective: To explore a process of the preparation of refine(non-bitter) Mornordica Charactia L, extract powder, and compare the effect on rat with diabetes between non-bitter and bitter powder. Method: Non-bitter Mornordica Charactia L. extract powder was obtained by macroporous resin. The effects of oral feeding of the extract in rat with streptozotocin-induced diabetes was also observed. Result: The powder was non-better and mild, and after the oral the powder for 6 weeks the blood glucose values in model rats were lowered, the weights of the rats were increased. There weren' t obvious differences between bitter powder and non-bitter powder. Conclusion: The process of removal of bitter was effective, easily manipulated.
机构地区 武汉大学药学院
出处 《中国药师》 CAS 2006年第9期795-797,共3页 China Pharmacist
关键词 精制苦瓜提取物 制备 药效 Refine Momordica Charactia L. Extract Preparation Effect
  • 相关文献

参考文献6

  • 1Manabe M, Takenaka Ryo, Nakasa T, et al. Induction of anti-in-flammatory responses by dietary Momordica charantia L. (bitter gourd) [ J]. Biosclenee Biotechnology and Biochemistry, 2003, 67(12) : 2512-2517
  • 2Cummings E, Hundal HS, Wackerhage H, et al. Momordica charantia fruit juice stimulates glucose and amino acid uptakes in L6 myotubes[ J]. Molecular and Cellular Biochemistry, 2004, 261 ( 1&2 ) :99-104
  • 3Harada H, Makino F, Iizuka H, et al. Inhibition of glycation by Momordica charantia L. and its influence on lipid metabolizing enzymes in streptozotocin-induced diabetic rats [ J ]. ITE Letters on Batteries,New Technologies & Medicine, 2002, 3(6): 727-731
  • 4Fujimoto Kenshiro, Takamiya Kenji, Matsumoto Wataru. Antitumor compositions containing Momordica charantia seed oil [ P ].JP2002205953,2002
  • 5Lee-Huang Sylvia. Preparation of truncated Momordica charantia anti-HIV and anti-tumor MAP30 or GAP31 proteins [ P]. US6652861,2003
  • 6Aitani Norio, Shimoda Hiroshi, Okada Tadashi, et al. Composition containing bitter gourd ( Momordica charantia ) components for lipid metabolism improvement, and their use for foods, beverages, pharmaceuticals, and cosmetics [ P]. JP2005126370, 2005

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部